We’re excited to join forces with Newsight Tech Angels to launch the inaugural “Cross-Border Biotech: Taiwan-Japan Investment Pitch,” an event designed to unite the biotech communities of Taiwan and Japan, create cross-border investment opportunities, and spark collaborations to drive innovation in biotech and healthcare.
📅 Date: December 4, 2024
📍 Location: National Biotechnology Research Park Room C212, Academia Sinica, Taiwan
⏰ Time: 14:00 – 18:00 (Registration starts at 13:30)
Event Agenda:
- 13:30 – 14:00 Registration
- 14:00 – 14:05 Opening Remarks
- 14:05 – 15:10 Keynote Presentations
- 15:10 – 15:20 Intermission
- 15:20 – 16:45 Startup Pitches
- 16:45 – 16:50 Closing Remarks
- 16:50 – 18:00 Networking Session
Join us as top industry leaders—featuring Toru Jay Seo, Ph.D. (CEO of Newsight Tech Angels) and senior experts from PwC Taiwan and A2 Healthcare Taiwan—uncover exciting business opportunities across Taiwan and Japan. Prepare to gain valuable insights from the following inspiring keynote topics:
- Taiwan-Japan Biotech Industry Cross-Border Investment Opportunities
- Challenges and Solutions in Japan’s Startup Fundraising
- Challenges and Opportunities in the Biopharma Capital Markets of Japan and Taiwan
- Harmonization of regulations in Taiwan and Japan and its impact on clinical trials
Plus, get ready to discover these trailblazing startups:
- Cyto-Facto (Japan)
- Jocavio (Japan)
- Cellusion (Japan)
- Stratoimmune (Japan)
- Dr. Miyajima (Japan)
- DotBio (Taiwan & Singapore)
- Apexcella (Taiwan)
Be part of an exclusive opportunity to connect with top Taiwanese investors and biotech pioneers! Expand your network, explore collaborative opportunities, and engage with industry frontrunners shaping the future of biotech across borders. Don’t miss this unique chance to connect, learn, and invest in the future of biotech!
This event is proudly sponsored by EirGenix Inc., Cell-Bio Biotechnology Co., Ltd., TailorMed, J&H Technology Co., Ltd., Mithra Biotechnology, Mycenax, NKBiotech, Tseng Hsiang Life Science Ltd.
